Apyx Medical Corp Share Price Nasdaq
Equities
US03837C1062
Medical Equipment, Supplies & Distribution
Sales 2024 * | 49.94M 4.17B | Sales 2025 * | 54.52M 4.55B | Capitalization | 48.5M 4.05B |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.25B | Net income 2025 * | -25M -2.09B | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
-1.79
x | P/E ratio 2025 * |
-2.01
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15/17/15 |
Andrew Makrides
FOU | Founder | 82 | 01/78/01 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 01/78/01 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 15/11/15 |
Craig Swandal
BRD | Director/Board Member | 63 | 09/18/09 |
1st Jan change | Capi. | |
---|---|---|
-3.72% | 186B | |
-2.60% | 107B | |
-3.79% | 67.44B | |
+2.66% | 50.03B | |
+16.39% | 47.81B | |
+4.79% | 41.03B | |
+1.38% | 26.85B | |
+1.52% | 25.82B | |
-1.17% | 25.01B |